Novel Cyano‐Artemisinin Dimer ZQJ29 Targets PARP1 to Induce Ferroptosis in Pancreatic Cancer Treatment
Advanced Science · 2025
DOI: 10.1002/advs.202501935 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Science, 2025. Verfasst von Jianping Chen und 9 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Discovery and Utilization of Functional Components in Traditional Chinese Medicine, Shanghai Frontiers Science Center for TCM…. Hauptthemen laut MEDLINE: Ferroptosis, Pancreatic Neoplasms, Poly (ADP-Ribose) Polymerase-1, Artemisinins. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 59 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Shanghai University of Traditional Chinese Medicine.
Abstract (Originalsprache)
Pancreatic cancer remains one of the most lethal malignancies in the digestive system, with limited available drugs and a need for improved efficacy. This unmet clinical need highlights the urgency to discover novel, highly efficient small‐molecule compounds. Herein, a novel cyano‐containing artemisinin dimer derivative, ZQJ29, is synthesized through structural modifications of artemisinin. Biological evaluation demonstrated that ZQJ29 effectively inhibits the proliferation of pancreatic cancer cells both in vitro and in vivo. ZQJ29 selectively targets PARP1 and has distinct structural features comparable to established PARP1 inhibitors such as Olaparib. Notably, ZQJ29 is the first reported artemisinin derivative to inhibit PARP1. Furthermore, the inhibition of PARP1 by ZQJ29 enhances the expression of TP53 and inhibits the SLC7A11/GPX4 pathway. The work first demonstrates that targeting PARP1 can induce ferroptosis in pancreatic cancer. These findings not only identify promising artemisinin derivatives for the development of therapies targeting pancreatic cancer but also provide scientific evidence supporting therapeutic strategies aimed at inducing ferroptosis in pancreatic cancer. This research lays a robust foundation for subsequent preclinical studies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- State Key Laboratory of Discovery and Utilization of Functional Components in Traditional Chinese Medicine, Shanghai Frontiers Science Center for TCM Chemical Biology, Innovation Research Institute of Traditional Chines…
- Institute of Interdisciplinary Integrative Medicine Research, Shanghai University of Traditional Chinese Medicine, Shanghai, 201203, China.
- Department of Chemistry, College of Sciences, Shanghai University, Shanghai, 200444, China.
- School of Pharmacy, Shanghai University of Traditional Chinese Medicine, Shanghai, 201203, China.
- College of Mathematics and Physics, Shanghai University of Electric Power, Shanghai, 201306, China.
ORCID-Profile: Qingjie Zhao
Förderung
- Shanghai University of Traditional Chinese Medicine
Zitieren
APA
Chen, J., Yue, L., Pan, Y., Jiang, B., Wan, J., Lin, H., Guo, F., Li, H., Li, Y., & Zhao, Q. (2025). Novel Cyano‐Artemisinin Dimer ZQJ29 Targets PARP1 to Induce Ferroptosis in Pancreatic Cancer Treatment. Advanced Science. https://doi.org/10.1002/advs.202501935
Vancouver
Chen J, Yue L, Pan Y, Jiang B, Wan J, Lin H, et al. Novel Cyano‐Artemisinin Dimer ZQJ29 Targets PARP1 to Induce Ferroptosis in Pancreatic Cancer Treatment. Advanced Science. 2025. doi:10.1002/advs.202501935
BibTeX
@article{Chen2025,
author = {Chen, Jianping and Yue, Lingyun and Pan, Yanna and Jiang, Bingying and Wan, Junfeng and Lin, Haixia and Guo, Fujiang and Li, Huiyu and Li, Yajuan and Zhao, Qingjie},
title = {Novel Cyano‐Artemisinin Dimer ZQJ29 Targets PARP1 to Induce Ferroptosis in Pancreatic Cancer Treatment},
journal = {Advanced Science},
year = {2025},
doi = {10.1002/advs.202501935}
}
EUVIMED